심장 워크스테이션 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 용도별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Cardiac Workstation Market Size & Trends:

The global cardiac workstation market size was estimated at USD 363.26 million in 2024 and is projected to grow at a CAGR of 9.10% from 2025 to 2030. The cardiac workstation market is driven by the rising prevalence of cardiovascular diseases, increasing electrocardiogram (ECG) procedures, and the growing geriatric population, which is more susceptible to heart conditions. According to the data published by the Oxford University Press in November 2024, over 300 million ECGs are performed annually across the globe.

The rising incidence of cardiovascular diseases significantly drives the cardiac workstation market. According to the data published in the Journal of Cardiac Failure in January 2025, about 6.7 million individuals living in America over the age of 20 currently live with heart failure. This number is projected to increase by 70% over the forecast period, underscoring the growing burden of cardiovascular conditions. The incidence of heart failure in 2030, 2040, and 2050 is represented in the figure below. As the incidence of heart failure rises, there is a growing demand for advanced diagnostic and monitoring tools, such as cardiac workstations.

Moreover, according to the 2024 Heart Disease and Stroke Statistics Update by the American Heart Association, cardiovascular disease was the underlying cause of 931,578 deaths in the U.S. in 2021-surpassing deaths from all forms of cancer and chronic lower respiratory diseases combined. This alarming statistic highlights the critical need for timely diagnosis and efficient management of cardiovascular conditions. As a result, the demand for cardiac workstations, which support comprehensive cardiovascular assessment and streamline clinical workflows, is witnessing substantial growth.

In addition, due to the growing burden of cardioavcular diseases across the globe, the number of ECG procedures is also increasing significantly. In the U.S. alone, over 100 million 12-lead ECGs are performed annually, making it the most commonly used diagnostic tool for detecting heart disease. Also, as per the data published in GE HealthCare's article in February 2023, more than 300 million ECGs are conducted each year globally across both acute care and ambulatory settings. Thus, the extensive need and large number of ECG procedures undertaken yearly are anticipated to boost the demand for cardiac workstations to streamline workflows, improve diagnostic precision, and meet the growing demand for effective cardiac care.

Global Cardiac Workstation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global cardiac workstation market report on the basis of end-use, distribution channel, and region

• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Ambulatory Surgical Centers
• Physician Offices/ Specialty Clinics/ Office Based Labs
• Skilled Nursing Facilities
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Medical Surge Distribution
• IT/ CDW/ VAR-Value Added Reseller
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. End Use
  • 1.1.2. Distribution Channel
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Workstation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cardiac disorders
    • 3.2.1.2. Rising number of ECG procedures
    • 3.2.1.3. Introduction of innovative and advanced products
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of awareness in some regions
    • 3.2.2.2. High treatment costs
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Improvements in public and private hospital infrastructure
    • 3.2.3.2. Growth potential in emerging economies in cardiac workstation market
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Product recalls
• 3.3. Cardiac Workstation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Cardiac Workstation Devices: End Use Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Cardiac Workstation Market Movement Analysis
• 4.3. Global Cardiac Workstation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 4.4. Hospitals
  • 4.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Ambulatory Surgery Centers
  • 4.5.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Physician Offices/ Specialty Clinics/ Office Based Labs
  • 4.6.1. Physician offices/ specialty clinics/ office based labs market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Skilled Nursing Facilities
  • 4.7.1. Skilled nursing facilities market estimates and forecast 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Cardiac Workstation Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Cardiac Workstation Market Movement Analysis
• 5.3. Global Cardiac Workstation Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 5.4. Medical Surge Distribution
  • 5.4.1. Medical surge distribution market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. IT/ CDW/ VAR-(Value Added Reseller)
  • 5.5.1. IT/ CDW/ VAR-(Value Added Reseller) market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Cardiac Workstation Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Competitive scenario
    • 6.3.2.3. Regulatory framework
    • 6.3.2.4. Reimbursement scenario
    • 6.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Competitive scenario
    • 6.3.3.3. Regulatory framework
    • 6.3.3.4. Reimbursement scenario
    • 6.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Competitive scenario
    • 6.3.4.3. Regulatory framework
    • 6.3.4.4. Reimbursement scenario
    • 6.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Competitive scenario
    • 6.4.1.3. Regulatory framework
    • 6.4.1.4. Reimbursement scenario
    • 6.4.1.5. UK market estimates and forecasts, 2018 - 2030
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Competitive scenario
    • 6.4.2.3. Regulatory framework
    • 6.4.2.4. Reimbursement scenario
    • 6.4.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Competitive scenario
    • 6.4.3.3. Regulatory framework
    • 6.4.3.4. Reimbursement scenario
    • 6.4.3.5. France market estimates and forecasts, 2018 - 2030
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Competitive scenario
    • 6.4.4.3. Regulatory framework
    • 6.4.4.4. Reimbursement scenario
    • 6.4.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Competitive scenario
    • 6.4.5.3. Regulatory framework
    • 6.4.5.4. Reimbursement scenario
    • 6.4.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 6.4.6. Denmark
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Competitive scenario
    • 6.4.6.3. Regulatory framework
    • 6.4.6.4. Reimbursement scenario
    • 6.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Competitive scenario
    • 6.4.7.3. Regulatory framework
    • 6.4.7.4. Reimbursement scenario
    • 6.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Competitive scenario
    • 6.4.8.3. Regulatory framework
    • 6.4.8.4. Reimbursement scenario
    • 6.4.8.5. Norway market estimates and forecasts, 2018 - 2030
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework
    • 6.5.1.4. Reimbursement scenario
    • 6.5.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 6.5.2. India
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. India market estimates and forecasts, 2018 - 2030
  • 6.5.3. China
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. China market estimates and forecasts, 2018 - 2030
  • 6.5.4. South Korea
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Competitive scenario
    • 6.5.4.3. Regulatory framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Competitive scenario
    • 6.5.5.3. Regulatory framework
    • 6.5.5.4. Reimbursement scenario
    • 6.5.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Competitive scenario
    • 6.5.6.3. Regulatory framework
    • 6.5.6.4. Reimbursement scenario
    • 6.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Competitive scenario
    • 6.6.1.3. Regulatory framework
    • 6.6.1.4. Reimbursement scenario
    • 6.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement scenario
    • 6.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
• 7.4. Global Key company market share analysis, 2024
  • 7.4.1. Koninklijke Philips N.V
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. GE HealthCare
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Baxter (Hillrom Services, Inc.)
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. AFC Industries, Inc.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. SCHILLER AG
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. EDAN Instruments, Inc.
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Medtronic
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. CONTEC MEDICAL SYSTEMS CO.,LTD
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Lepu Medical Technology(Beijing)Co.,Ltd.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Cardioline S.P.A.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
• 7.5. Heat Map Analysis/ Company Market Position Analysis
• 7.6. Estimated Company Market Share Analysis, 2024
• 7.7. List of Other Key Market Player